Radcliffe Capital Management’s CERo Therapeutics Holdings, Inc. Warrants CEROW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-149,380
| Closed | -$4.11K | – | 86 |
|
|
2023
Q4 | $4.11K | Sell |
149,380
-620
| -0.4% | -$17 | ﹤0.01% | 153 |
|
|
2023
Q3 | $11.5K | Hold |
150,000
| – | – | ﹤0.01% | 331 |
|
|
2023
Q2 | $9.82K | Hold |
150,000
| – | – | ﹤0.01% | 419 |
|
|
2023
Q1 | $6.01K | Hold |
150,000
| – | – | ﹤0.01% | 601 |
|
|
2022
Q4 | $1.54M | Hold |
150,000
| – | – | 0.05% | 547 |
|
|
2022
Q3 | $1.51M | Hold |
150,000
| – | – | 0.04% | 759 |
|
|
2022
Q2 | $1.5M | Hold |
150,000
| – | – | 0.03% | 793 |
|
|
2022
Q1 | $1.5M | Hold |
150,000
| – | – | 0.03% | 773 |
|
|
2021
Q4 | $1.49M | Buy |
+150,000
| New | +$1.49M | 0.04% | 674 |
|